Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease

Metabolomic profiling in children with inflammatory bowel disease

(2020) Aleksandra Filimoniuk et al.   Advances in Medical Sciences

Metabonomics and the gut microbiome associated with primary response to anti-TNF therapy in Crohn’s disease

(2020) N S Ding et al.   Journal of Crohns & Colitis

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

(2020) Aonghus Lavelle et al.   Nature Reviews Gastroenterology & Hepatology

M2IA: a web server for microbiome and metabolome integrative analysis

(2020) Yan Ni et al.   BIOINFORMATICS

The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases

(2020) Nikolas Dovrolis et al.   Microorganisms

Metabolome–Microbiome Crosstalk and Human Disease

(2020) Kathleen A. Lee-Sarwar et al.   Metabolites

Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn’s Disease

(2020) Xiaojun Zhuang et al.   INFLAMMATORY BOWEL DISEASES

Microbial network disturbances in relapsing refractory Crohn’s disease

(2019) Bahtiyar Yilmaz et al.   NATURE MEDICINE

Untargeted Metabolomics and Inflammatory Markers Profiling in Children With Crohn’s Disease and Ulcerative Colitis—A Preliminary Study

(2019) Urszula Daniluk et al.   INFLAMMATORY BOWEL DISEASES

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection

(2019) Benjamin H Mullish et al.   GUT

Malassezia Is Associated with Crohn’s Disease and Exacerbates Colitis in Mouse Models

(2019) Jose J. Limon et al.   Cell Host & Microbe

Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients with Inflammatory Bowel Diseases

(2019) Konrad Aden et al.   GASTROENTEROLOGY

Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis

(2019) Xinyang Song et al.   NATURE

Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn’s disease

(2019) Kinga Kowalska-Duplaga et al.   Scientific Reports

Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis

(2019) Yizhong Wang et al.   mSystems

Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders

(2018) P. A. Gill et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis

(2018) Jasmine Chong et al.   NUCLEIC ACIDS RESEARCH

Diversion colitis and pouchitis: A mini-review

(2018) Kentaro Tominaga et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction

(2018) Youlian Zhou et al.   mSystems

Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients

(2018) T. G. J. de Meij et al.   PLoS One

Gut microbiome structure and metabolic activity in inflammatory bowel disease

(2018) Eric A. Franzosa et al.   Nature Microbiology

Characteristics of Faecal Microbiota in Paediatric Crohn’s Disease and Their Dynamic Changes During Infliximab Therapy

(2017) Yizhong Wang et al.   Journal of Crohns & Colitis

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

(2017) Siew C Ng et al.   LANCET

Gut microbiota and IBD: causation or correlation?

(2017) Josephine Ni et al.   Nature Reviews Gastroenterology & Hepatology

A role for bacterial urease in gut dysbiosis and Crohn’s disease

(2017) Josephine Ni et al.   Science Translational Medicine

Calypso: a user-friendly web-server for mining and visualizing microbiome–environment interactions

(2016) Martha Zakrzewski et al.   BIOINFORMATICS

Fungal microbiota dysbiosis in IBD

(2016) Harry Sokol et al.   GUT

Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis

(2016) Guoxiang Xie et al.   INTERNATIONAL JOURNAL OF CANCER

Fungal Microbiota Profile in Newly Diagnosed Treatment-naïve Children with Crohn’s disease

(2016) Mohammad El Mouzan et al.   Journal of Crohns & Colitis

Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition

(2016) Maria K. Magnusson et al.   Journal of Crohns & Colitis

Faecal and serum metabolomics in paediatric inflammatory bowel disease

(2016) Kaija-Leena Kolho et al.   Journal of Crohns & Colitis

Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management

(2015) N. S. Ding et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Extensive Modulation of the Fecal Metagenome in Children With Crohn’s Disease During Exclusive Enteral Nutrition

(2015) Christopher Quince et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease

(2015) Christel Chehoud et al.   INFLAMMATORY BOWEL DISEASES

Altered Fecal Microbiota in Paediatric Inflammatory Bowel Disease

(2015) Johanna Maukonen et al.   Journal of Crohns & Colitis

Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn’s Disease Patients

(2015) Giuseppina Liguori et al.   Journal of Crohns & Colitis

The fungal microbiota of de-novo paediatric inflammatory bowel disease

(2015) I. Mukhopadhya et al.   MICROBES AND INFECTION

Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome

(2015) Laurence Macia et al.   Nature Communications

The Treatment-Naive Microbiome in New-Onset Crohn’s Disease

(2014) Dirk Gevers et al.   Cell Host & Microbe

Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD

(2014) Vicky De Preter et al.   GUT

Finding the Missing Links among Metabolites, Microbes, and the Host

(2014) Pieter C. Dorrestein et al.   IMMUNITY

Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohnʼs Disease

(2014) Sylvie Rajca et al.   INFLAMMATORY BOWEL DISEASES

Bacterial Bile Metabolising Gene Abundance in Crohn's, Ulcerative Colitis and Type 2 Diabetes Metagenomes

(2014) Alain Labbé et al.   PLoS One

A decrease of the butyrate-producing speciesRoseburia hominisandFaecalibacterium prausnitziidefines dysbiosis in patients with ulcerative colitis

(2013) Kathleen Machiels et al.   GUT

The ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents

(2013) Arie Levine et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis

(2013) P. M. Smith et al.   SCIENCE

Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats

(2011) K.B.M. Saiful Islam et al.   GASTROENTEROLOGY

Search and clustering orders of magnitude faster than BLAST

(2010) Robert C. Edgar   BIOINFORMATICS

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

(2010) Matthieu Allez et al.   Journal of Crohns & Colitis

Bile Salts Control the Antimicrobial Peptide Cathelicidin Through Nuclear Receptors in the Human Biliary Epithelium

(2008) Emilie D'Aldebert et al.   GASTROENTEROLOGY

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

(2008) H. Sokol et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA